These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3825371)

  • 21. [Latent endogenous depressions. II. Clinical systematics].
    Anufriev AK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(8):1202-8. PubMed ID: 696110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TEMPS-A: progress towards validation of a self-rated clinical version of the Temperament Evaluation of the Memphis, Pisa, Paris, and San Diego Autoquestionnaire.
    Akiskal HS; Akiskal KK; Haykal RF; Manning JS; Connor PD
    J Affect Disord; 2005 Mar; 85(1-2):3-16. PubMed ID: 15780671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-dose valproate: a new treatment for cyclothymia, mild rapid cycling disorders, and premenstrual syndrome.
    Jacobsen FM
    J Clin Psychiatry; 1993 Jun; 54(6):229-34. PubMed ID: 8331092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Endogenous-phasic psychosis at the brink of adolescence].
    Wiesse J; Mattejat F
    Acta Paedopsychiatr; 1982 Feb; 47(6):341-9. PubMed ID: 7044031
    [No Abstract]   [Full Text] [Related]  

  • 25. Searching for behavioral indicators of bipolar II in patients presenting with major depressive episodes: the "red sign," the "rule of three" and other biographic signs of temperamental extravagance, activation and hypomania.
    Akiskal HS
    J Affect Disord; 2005 Feb; 84(2-3):279-90. PubMed ID: 15708427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Course and form variations of cyclothymic phases in lithium therapy].
    Banzhaf M; Bertram W; Schulze F
    Psychiatr Neurol Med Psychol (Leipz); 1985 Dec; 37(12):718-21. PubMed ID: 3938025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validating affective temperaments in their subaffective and socially positive attributes: psychometric, clinical and familial data from a French national study.
    Akiskal HS; Akiskal K; Allilaire JF; Azorin JM; Bourgeois ML; Sechter D; Fraud JP; Chatenêt-Duchêne L; Lancrenon S; Perugi G; Hantouche EG
    J Affect Disord; 2005 Mar; 85(1-2):29-36. PubMed ID: 15780673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Affective temperaments in the bipolar and unipolar disorders: distinctive profiles and relationship with clinical features].
    Gassab L; Mechri A; Bacha M; Gaddour N; Gaha L
    Encephale; 2008 Oct; 34(5):477-82. PubMed ID: 19068336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative study of substance dependence comorbidity in bipolar, schizophrenic and schizoaffective disorders].
    Verdoux H; Mury M; Besançon G; Bourgeois M
    Encephale; 1996; 22(2):95-101. PubMed ID: 8706627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Description and validation of the Affective Temperament Questionnaire.
    Light KJ; Joyce PR; Frampton CM
    Compr Psychiatry; 2009; 50(5):477-84. PubMed ID: 19683619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Importance of DSM IV (APA) and ICD-10 (WHO) in diagnosis and treatment of mood disorders].
    Bourgeois M
    Encephale; 1995 Dec; 21 Spec No 5():47-52. PubMed ID: 8582307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TEMPS-A: validation of a short version of a self-rated instrument designed to measure variations in temperament.
    Akiskal HS; Mendlowicz MV; Jean-Louis G; Rapaport MH; Kelsoe JR; Gillin JC; Smith TL
    J Affect Disord; 2005 Mar; 85(1-2):45-52. PubMed ID: 15780675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Alexithymia in negative symptom and non-negative symptom schizophrenia].
    Nkam I; Langlois-Thery S; Dollfus S; Petit M
    Encephale; 1997; 23(5):358-63. PubMed ID: 9453928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cyclothymic temperament in healthy controls and familially at risk individuals for mood disorder: endophenotype for genetic studies?
    Chiaroni P; Hantouche EG; Gouvernet J; Azorin JM; Akiskal HS
    J Affect Disord; 2005 Mar; 85(1-2):135-45. PubMed ID: 15780684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of emotion clarity on emotional prosody identification in paranoid schizophrenia.
    Bach DR; Buxtorf K; Grandjean D; Strik WK
    Psychol Med; 2009 Jun; 39(6):927-38. PubMed ID: 19000339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A momentary assessment study of the reputed emotional phenotype associated with borderline personality disorder.
    Glaser JP; Van Os J; Mengelers R; Myin-Germeys I
    Psychol Med; 2008 Sep; 38(9):1231-9. PubMed ID: 18047769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A study of affective temperaments in Hungary: internal consistency and concurrent validity of the TEMPS-A against the TCI and NEO-PI-R.
    Rózsa S; Rihmer Z; Gonda X; Szili I; Rihmer A; Ko N; Németh A; Pestality P; Bagdy G; Alhassoon O; Akiskal KK; Akiskal HS
    J Affect Disord; 2008 Feb; 106(1-2):45-53. PubMed ID: 17706791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Schizophrenia and addiction: An evaluation of the self-medication hypothesis].
    Potvin S; Stip E; Roy JY
    Encephale; 2003; 29(3 Pt 1):193-203. PubMed ID: 12876543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bulimia nervosa in atypical depression: the mediating role of cyclothymic temperament.
    Perugi G; Toni C; Passino MC; Akiskal KK; Kaprinis S; Akiskal HS
    J Affect Disord; 2006 May; 92(1):91-7. PubMed ID: 16436300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The location of the deficits of emotional communication in dimensional models of schizophrenia].
    Kucharska-Pietura K; Masiak M
    Psychiatr Pol; 2004; 38(5):809-18. PubMed ID: 15523928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.